39 results
8-K
EX-99.1
GERN
Geron Corp.
30 Jul 04
Financial statements and exhibits
12:00am
of the Asian territory development and marketing
rights for telomerase inhibitors that had been granted to
Kyowa Hakko. Geron now holds all
8-K
EX-99.1
GERN
Geron Corp.
30 Jun 04
Other events
12:00am
development programs. Kyowa Hakko has therefore returned
Asian territory development and marketing rights for Geron's
telomerase inhibitors.
"Geron has
8-K
GERN
Geron Corp.
30 Jun 04
Other events
12:00am
corporation (the "Company"), and
Kyowa Hakko Kogyo Co., Ltd. announced that Kyowa Hakko has returned Asian
territory development and marketing rights
8-K
EX-99.1
683p6bif0q
22 Aug 01
Other events
12:00am
8-K
EX-99.1
sf2 g13u8qwuhq
31 Jan 01
Current report
12:00am